Lagios Diagnostics

Lagios Diagnostics was founded in November 2016 and operates in the sector of In Vitro Diagnostics (IVDs). The Company is a member of Lagios HealthCare Group which operates 10 organizations offering a wide range of healthcare products and services in the territories of Greece, Albania and Kosovo. Company’s mission is to provide high quality In Vitro Diagnostics solutions in the Greek and international market and support the Healthcare Professionals to cover their unmet medical needs. The company’s offices are based in Athens and its branch office is located in Thessaloniki. Lagios Diagnostics’ team is manned of experienced, trained, scientifically and technically qualified people that can cover the continuously developing market needs. Today, Lagios Diagnostics is the exclusive distributor of Urinalysis systems of SYSMEX in Greece, the global leader in Urology testing. Our distributionships also include RANDOX, the company with the widest external quality assessment (EQA) system in the world, DetectaChem with an FDA authorized Covid-19 molecular testing system and SNIBE of P.R. China. The Company supplies diagnostic laboratories, clinics, hospitals and IVD resellers/retailers. Lagios Diagnostics is compelled to offer products complied completely to national and international quality standards and the legislature in effect. For this reason, the company implements and follows a complete Quality Assurance System accordingly to the International ISO Standard 9001:2015 and the respective Greek Ministerial Decision referring to the good practice implemented in the In Vitro Diagnostics field. The discrete scientific and technical support departments of the Company are fully complied with Manufacturers directives and they ready to immediately respond, strengthening our collaboration with the Healthcare Professionals and reassuring the quality of the services offered to their patients.